Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Capsule FMT for CRE Decolonization
NCT03527056Phase 1Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2019
- Primary completion
- Sep 2019
- Modality
- Live Biotherapeutic Products
01
Overview
Phase 1, randomised, open-label trial of Fecal Microbiota Transplantation Capsule in Enterobacteriaceae colonization (2 arms), sponsored by University of California, Los Angeles. Primary endpoints: Proportion of participants with CRE decolonization at 10 days and Proportion of participants with an adverse event at 10 days. Planned start Jun 2019; status: withdrawn.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Enterobacteriaceae colonization
Beyond the preview
Go deeper on NCT03527056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03527056.